Global Immune Thrombocytopenic Purpura Therapeutics Market Professional Survey Report 2019

Table of Contents

Executive Summary

1 Industry Overview of Immune Thrombocytopenic Purpura Therapeutics

• 1.1 Definition of Immune Thrombocytopenic Purpura Therapeutics
• 1.2 Immune Thrombocytopenic Purpura Therapeutics Segment by Type
  • 1.2.1 Global Immune Thrombocytopenic Purpura Therapeutics Production Growth Rate Comparison by Types (2014-2025)
  • 1.2.2 Eltrombopag Olamine
  • 1.2.3 Fostamatinib Disodium
  • 1.2.4 GL-2045
  • 1.2.5 Avatrombopag
  • 1.2.6 BI-655064
  • 1.2.7 Others
• 1.3 Immune Thrombocytopenic Purpura Therapeutics Segment by Applications
  • 1.3.1 Global Immune Thrombocytopenic Purpura Therapeutics Consumption Comparison by Applications (2014-2025)
  • 1.3.2 Hospital
  • 1.3.3 Clinic
  • 1.3.4 Others
• 1.4 Global Immune Thrombocytopenic Purpura Therapeutics Overall Market
  • 1.4.1 Global Immune Thrombocytopenic Purpura Therapeutics Revenue (2014-2025)
  • 1.4.2 Global Immune Thrombocytopenic Purpura Therapeutics Production (2014-2025)
  • 1.4.3 North America Immune Thrombocytopenic Purpura Therapeutics Status and Prospect (2014-2025)
  • 1.4.4 Europe Immune Thrombocytopenic Purpura Therapeutics Status and Prospect (2014-2025)
  • 1.4.5 China Immune Thrombocytopenic Purpura Therapeutics Status and Prospect (2014-2025)
  • 1.4.6 Japan Immune Thrombocytopenic Purpura Therapeutics Status and Prospect (2014-2025)
  • 1.4.7 Southeast Asia Immune Thrombocytopenic Purpura Therapeutics Status and Prospect (2014-2025)
  • 1.4.8 India Immune Thrombocytopenic Purpura Therapeutics Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis

• 2.1 Raw Material and Suppliers
• 2.2 Manufacturing Cost Structure Analysis of Immune Thrombocytopenic Purpura Therapeutics
• 2.3 Manufacturing Process Analysis of Immune Thrombocytopenic Purpura Therapeutics
• 2.4 Industry Chain Structure of Immune Thrombocytopenic Purpura Therapeutics

3 Development and Manufacturing Plants Analysis of Immune Thrombocytopenic Purpura Therapeutics

• 3.1 Capacity and Commercial Production Date
• 3.2 Global Immune Thrombocytopenic Purpura Therapeutics Manufacturing Plants Distribution
• 3.3 Major Manufacturers Technology Source and Market Position of Immune Thrombocytopenic Purpura Therapeutics
• 3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers

• 4.1 Immune Thrombocytopenic Purpura Therapeutics Production and Capacity Analysis
• 4.2 Immune Thrombocytopenic Purpura Therapeutics Revenue Analysis
• 4.3 Immune Thrombocytopenic Purpura Therapeutics Price Analysis
• 4.4 Market Concentration Degree

5 Immune Thrombocytopenic Purpura Therapeutics Regional Market Analysis

• 5.1 Immune Thrombocytopenic Purpura Therapeutics Production by Regions
  • 5.1.1 Global Immune Thrombocytopenic Purpura Therapeutics Production by Regions
  • 5.1.2 Global Immune Thrombocytopenic Purpura Therapeutics Revenue by Regions
• 5.2 Immune Thrombocytopenic Purpura Therapeutics Consumption by Regions
• 5.3 North America Immune Thrombocytopenic Purpura Therapeutics Market Analysis
  • 5.3.1 North America Immune Thrombocytopenic Purpura Therapeutics Production
  • 5.3.2 North America Immune Thrombocytopenic Purpura Therapeutics Revenue
  • 5.3.3 Key Manufacturers in North America
  • 5.3.4 North America Immune Thrombocytopenic Purpura Therapeutics Import and Export
• 5.4 Europe Immune Thrombocytopenic Purpura Therapeutics Market Analysis
  • 5.4.1 Europe Immune Thrombocytopenic Purpura Therapeutics Production
  • 5.4.2 Europe Immune Thrombocytopenic Purpura Therapeutics Revenue
  • 5.4.3 Key Manufacturers in Europe
  • 5.4.4 Europe Immune Thrombocytopenic Purpura Therapeutics Import and Export
• 5.5 China Immune Thrombocytopenic Purpura Therapeutics Market Analysis
  • 5.5.1 China Immune Thrombocytopenic Purpura Therapeutics Production
  • 5.5.2 China Immune Thrombocytopenic Purpura Therapeutics Revenue
  • 5.5.3 Key Manufacturers in China
  • 5.5.4 China Immune Thrombocytopenic Purpura Therapeutics Import and Export
• 5.6 Japan Immune Thrombocytopenic Purpura Therapeutics Market Analysis
  • 5.6.1 Japan Immune Thrombocytopenic Purpura Therapeutics Production
  • 5.6.2 Japan Immune Thrombocytopenic Purpura Therapeutics Revenue
  • 5.6.3 Key Manufacturers in Japan
  • 5.6.4 Japan Immune Thrombocytopenic Purpura Therapeutics Import and Export
• 5.7 Southeast Asia Immune Thrombocytopenic Purpura Therapeutics Market Analysis
  • 5.7.1 Southeast Asia Immune Thrombocytopenic Purpura Therapeutics Production
  • 5.7.2 Southeast Asia Immune Thrombocytopenic Purpura Therapeutics Revenue
  • 5.7.3 Key Manufacturers in Southeast Asia
  • 5.7.4 Southeast Asia Immune Thrombocytopenic Purpura Therapeutics Import and Export
• 5.8 India Immune Thrombocytopenic Purpura Therapeutics Market Analysis
  • 5.8.1 India Immune Thrombocytopenic Purpura Therapeutics Production
  • 5.8.2 India Immune Thrombocytopenic Purpura Therapeutics Revenue
  • 5.8.3 Key Manufacturers in India
  • 5.8.4 India Immune Thrombocytopenic Purpura Therapeutics Import and Export

6 Immune Thrombocytopenic Purpura Therapeutics Segment Market Analysis (by Type)

• 6.1 Global Immune Thrombocytopenic Purpura Therapeutics Production by Type
• 6.2 Global Immune Thrombocytopenic Purpura Therapeutics Revenue by Type
• 6.3 Immune Thrombocytopenic Purpura Therapeutics Price by Type

7 Immune Thrombocytopenic Purpura Therapeutics Segment Market Analysis (by Application)

• 7.1 Global Immune Thrombocytopenic Purpura Therapeutics Consumption by Application
• 7.2 Global Immune Thrombocytopenic Purpura Therapeutics Consumption Market Share by Application (2014-2019)

8 Immune Thrombocytopenic Purpura Therapeutics Major Manufacturers Analysis

• 8.1 Amgen Inc.
  • 8.1.1 Amgen Inc. Immune Thrombocytopenic Purpura Therapeutics Production Sites and Area Served
  • 8.1.2 Amgen Inc. Product Introduction, Application and Specification
  • 8.1.3 Amgen Inc. Immune Thrombocytopenic Purpura Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.1.4 Main Business and Markets Served
• 8.2 Baxalta Incorporated
  • 8.2.1 Baxalta Incorporated Immune Thrombocytopenic Purpura Therapeutics Production Sites and Area Served
  • 8.2.2 Baxalta Incorporated Product Introduction, Application and Specification
  • 8.2.3 Baxalta Incorporated Immune Thrombocytopenic Purpura Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.2.4 Main Business and Markets Served
• 8.3 Boehringer Ingelheim GmbH
  • 8.3.1 Boehringer Ingelheim GmbH Immune Thrombocytopenic Purpura Therapeutics Production Sites and Area Served
  • 8.3.2 Boehringer Ingelheim GmbH Product Introduction, Application and Specification
  • 8.3.3 Boehringer Ingelheim GmbH Immune Thrombocytopenic Purpura Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.3.4 Main Business and Markets Served
• 8.4 Bristol-Myers Squibb Company
  • 8.4.1 Bristol-Myers Squibb Company Immune Thrombocytopenic Purpura Therapeutics Production Sites and Area Served
  • 8.4.2 Bristol-Myers Squibb Company Product Introduction, Application and Specification
  • 8.4.3 Bristol-Myers Squibb Company Immune Thrombocytopenic Purpura Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.4.4 Main Business and Markets Served
• 8.5 Eisai
  • 8.5.1 Eisai Immune Thrombocytopenic Purpura Therapeutics Production Sites and Area Served
  • 8.5.2 Eisai Product Introduction, Application and Specification
  • 8.5.3 Eisai Immune Thrombocytopenic Purpura Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.5.4 Main Business and Markets Served
• 8.6 Hansa Medical AB
  • 8.6.1 Hansa Medical AB Immune Thrombocytopenic Purpura Therapeutics Production Sites and Area Served
  • 8.6.2 Hansa Medical AB Product Introduction, Application and Specification
  • 8.6.3 Hansa Medical AB Immune Thrombocytopenic Purpura Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.6.4 Main Business and Markets Served
• 8.7 Immunomedics, Inc.
  • 8.7.1 Immunomedics, Inc. Immune Thrombocytopenic Purpura Therapeutics Production Sites and Area Served
  • 8.7.2 Immunomedics, Inc. Product Introduction, Application and Specification
  • 8.7.3 Immunomedics, Inc. Immune Thrombocytopenic Purpura Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.7.4 Main Business and Markets Served
• 8.8 Intas Pharmaceuticals Ltd.
  • 8.8.1 Intas Pharmaceuticals Ltd. Immune Thrombocytopenic Purpura Therapeutics Production Sites and Area Served
  • 8.8.2 Intas Pharmaceuticals Ltd. Product Introduction, Application and Specification
  • 8.8.3 Intas Pharmaceuticals Ltd. Immune Thrombocytopenic Purpura Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.8.4 Main Business and Markets Served
• 8.9 Jiangsu Hengrui Medicine Co., Ltd.
  • 8.9.1 Jiangsu Hengrui Medicine Co., Ltd. Immune Thrombocytopenic Purpura Therapeutics Production Sites and Area Served
  • 8.9.2 Jiangsu Hengrui Medicine Co., Ltd. Product Introduction, Application and Specification
  • 8.9.3 Jiangsu Hengrui Medicine Co., Ltd. Immune Thrombocytopenic Purpura Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.9.4 Main Business and Markets Served
• 8.10 Merck & Co., Inc.
  • 8.10.1 Merck & Co., Inc. Immune Thrombocytopenic Purpura Therapeutics Production Sites and Area Served
  • 8.10.2 Merck & Co., Inc. Product Introduction, Application and Specification
  • 8.10.3 Merck & Co., Inc. Immune Thrombocytopenic Purpura Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.10.4 Main Business and Markets Served
• 8.11 Momenta Pharmaceuticals, Inc.
• 8.12 Novartis AG
• 8.13 Pfizer Inc.

9 Development Trend of Analysis of Immune Thrombocytopenic Purpura Therapeutics Market

• 9.1 Global Immune Thrombocytopenic Purpura Therapeutics Market Trend Analysis
  • 9.1.1 Global Immune Thrombocytopenic Purpura Therapeutics Market Size (Volume and Value) Forecast 2019-2025
• 9.2 Immune Thrombocytopenic Purpura Therapeutics Regional Market Trend
  • 9.2.1 North America Immune Thrombocytopenic Purpura Therapeutics Forecast 2019-2025
  • 9.2.2 Europe Immune Thrombocytopenic Purpura Therapeutics Forecast 2019-2025
  • 9.2.3 China Immune Thrombocytopenic Purpura Therapeutics Forecast 2019-2025
  • 9.2.4 Japan Immune Thrombocytopenic Purpura Therapeutics Forecast 2019-2025
  • 9.2.5 Southeast Asia Immune Thrombocytopenic Purpura Therapeutics Forecast 2019-2025
  • 9.2.6 India Immune Thrombocytopenic Purpura Therapeutics Forecast 2019-2025
• 9.3 Immune Thrombocytopenic Purpura Therapeutics Market Trend (Product Type)
• 9.4 Immune Thrombocytopenic Purpura Therapeutics Market Trend (Application)
• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.3 Immune Thrombocytopenic Purpura Therapeutics Customers

11 Market Dynamics

• 11.1 Market Trends
• 11.2 Opportunities
• 11.3 Market Drivers
• 11.4 Challenges
• 11.5 Influence Factors

12 Conclusion

13 Appendix

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List